Please login to the form below
Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
Data monitoring committee has not yet conducted any interim efficacy analysis of the shot
Lilly’s Q3 earnings slump on COVID-19 development costs, pricing pressures
Earnings were particularly impacted by lower demand for top diabetes drug Trulicity
Keytruda growth helps Merck to offset COVID-19 impact in Q3
Profits beat expectations in the third quarter of 2020
Novartis weathers the COVID-19 storm in Q3, lifts outlook
Core operating income increased by 11%, profits from net income drop
Bayer pays an initial $2bn for gene therapy firm AskBio
Acquisition will expand Bayers’s pipeline with preclinical/clinical candidates
Lilly buys biotech firm Disarm Therapeutics for $135m
Deal could eventually be worth up to $1.36bn
Roche to collaborate with Dyno on gene therapies for CNS/liver diseases
Dyno will use its CapsidMap platform to develop novel AAV vectors for improved gene therapies
J&J signs deal with EU for 200 million COVID-19 vaccine doses
EU member states will have an option to secure 200 million additional doses
BMS picks up cardiovascular specialist MyoKardia for $13.1bn
Acquisition will bolster pipeline with targeted cardiovascular therapies
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
BioNTech bolsters COVID-19 vaccine capacity with Novartis dealDeal will expand production capacity for BNT162b2 candidate
-
Gilead agrees $21bn buyout of ImmunomedicsPharma company gains rights to ADC Trodelvy
-
Merck signs separate agreements with Seattle Genetics for two cancer drugsMerck makes a $1bn equity investment in the biotech company
-
AbbVie signs immunotherapy pact with I-Mab worth $2bn Focus of deal is anti-CD47 monoclonal antibody lemzoparlimab
-
Gavi says 76 wealthy countries have committed to COVAX vaccine facilityCountries have signed intent to joining COVID-19 vaccine initiative
-
Nestlé is set to acquire Aimmune in deal worth $2.6bnAimmune’s Palforzia therapy is the only FDA-approved peanut allergy drug
-
Novacyt launches diagnostic test to differentiate between COVID-19 and fluTest launches in time for upcoming winter flu season
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
COVID-19 Updates and Daily News
Featured jobs
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- Send Us a Message
- Russia submits COVID-19 vaccine to WHO for emergency use listing
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- Article
- How will COVID-19 affect uptake of vaccinations against other diseases?...
- Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
- Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
- Podcast
- Living With Chronic Illness (Series one)...
Quick links
Infographics
